Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Adjei, George O ^a   Oduro Boatey, Collins ^a   Rodrigues, Onike P ^a   Hoegberg, Lotte C ^b   Alifrangis, Michael ^b   Kurtzhals, Jorgen A ^b   Goka, Bamenla Q ^a  

^a UNIVERSITY OF GHANA   (Ghana)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cardiotoxicity; Children; Combination therapy; Ghana; Malaria

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; DEETHYLAMODIAQUINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CARDIOTOXICITY; CHILD; DRUG BLOOD LEVEL; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; GHANA; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; PRESCHOOL CHILD; QT PROLONGATION; SCHOOL CHILD; SINGLE DRUG DOSE; SINUS BRADYCARDIA;

ADOLESCENT; AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; BRADYCARDIA; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; ELECTROCARDIOGRAPHY; ETHANOLAMINES; FEMALE; FLUORENES; GHANA; HUMANS; INFANT; MALARIA; MALE; RISK FACTORS;

EID: 84871017613     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-420     Document Type: Article

References (30)

1. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Adjei GO, Kurtzhals JA, Rodrigues OP, Alifrangis M, Hoegberg LC, Kitcher ED, Badoe EV, Lamptey R, Goka BQ, Malar J 2008 7 127 10.1186/1475-2875-7-127 18620577 (Pubitemid 352033070)
2. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Mårtensson A, Strömberg J, Sisowath C, Msellem MI, Gil JP, Montgomery SM, Olliaro P, Ali AS, Björkman A, Clin Infect Dis 2005 41 1079 1086 10.1086/444460 16163624 (Pubitemid 41429468)
3. Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, Cohuet S, D'Alessandro U, Djimdé A, Karema C, Guthmann JP, Hamour S, Ndiaye JL, Mårtensson A, Rwagacondo C, Sagara I, Same-Ekobo A, Sirima SB, van den Broek I, Yeka A, Taylor WR, Dorsey G, Randrianarivelojosia M, Malar J 2009 8 203 10.1186/1475-2875-8-203 19698172
4. Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients. Ngouesse B, Basco LK, Ringwald P, Keundjian A, Blackett KN, Am J Trop Med Hyg 2001 65 711 716 11791962 (Pubitemid 34051331)
5. Drug induced QT prolongation and torsades de pointes. Yap YG, Camm AJ, Heart 2003 89 1363 1372 10.1136/heart.89.11.1363 14594906 (Pubitemid 37311108)
6. The pharmacokinetics and electrocardiographic effects of chloroquine in healthy subjects. Bustos MD, Gay F, Diquet B, Thomare P, Warot D, Trop Med Parasitol 1994 45 83 86 7939166 (Pubitemid 24209644)
7. Fatal neurotoxicity of arteether and artemether. Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras JM, Levine BS, Heiffer MH, Schuster BG, Am J Trop Med Hyg 1994 51 251 259 7943542 (Pubitemid 24300815)
8. Studies on systemic pharmacological effects of artesunate. Zhao Y, J Trop Med Hyg 1985 88 391 396 3939245 (Pubitemid 16071064)
9. Cardiac effects of antimalarial treatment with halofantrine. Nosten F, ter Kuile FO, Luxemburger C, Woodrow C, Kyle DE, Chongsuphajaisiddhi T, White NJ, Lancet 1993 341 1054 1056 10.1016/0140-6736(93)92412-M 8096959 (Pubitemid 23114398)
10. Potentiation of halofantrine-induced QTc prolongation by mefloquine: correlation with blood concentrations of halofantrine. Lightbown ID, Lambert JP, Edwards G, Coker SJ, Br J Pharmacol 2001 132 197 204 10.1038/sj.bjp.0703823 11156578 (Pubitemid 32128449)
11. Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects. Lefèvre G, Carpenter P, Souppart C, Schmidli H, Martin JM, Lane A, Ward C, Amakye D, J Clin Pharmacol 2002 42 1147 1158 12362930
12. Comparison of the cardiac effects of the antimalarials co-artemether and halofantrine in healthy participants. Bindschedler M, Lefèvre G, Degen P, Sioufi A, Am J Trop Med Hyg 2002 66 293 298 12139223 (Pubitemid 34756099)
13. No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine. van Vugt M, Ezzet F, Nosten F, Gathmann I, Wilairatana P, Looareesuwan S, White NJ, Am J Trop Med Hyg 1999 61 964 967 10674679 (Pubitemid 30084122)
14. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Karunajeewa H, Lim C, Hung TY, Ilett KF, Denis MB, Socheat D, Davis TM, Br J Clin Pharmacol 2004 57 93 99 14678346 (Pubitemid 38067955)
15. Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria. Mytton OT, Ashley EA, Peto L, Price RN, La Y, Hae R, Singhasivanon P, White NJ, Nosten F, Am J Trop Med Hyg 2007 77 447 450 17827358 (Pubitemid 351844317)
16. Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in Plasmodium falciparum infected adults from Thailand. Krudsood S, Looareesuwan S, Wilairatama P, Leowattana W, Tangpukdee N, Chalermrut K, Ramanathan S, Navaratnam V, Olliaro P, Vaillant M, Kiechel JR, Taylor WR, Trop Med Int Health 2011 16 458 465 10.1111/j.1365-3156.2010.02714.x 21219551
17. Differences in beat-to-beat variability of the QT interval between day and night. Kostis WJ, Belina JC, Angiology 2000 51 905 911 10.1177/ 000331970005101103 11103859
18. Prolongation of the QTc interval in African children treated for falciparum malaria. Price RN, Nosten F, White NJ, Am J Trop Med Hyg 1998 59 503 9790416
19. Cardiotoxicity of antimalarial drugs. White NJ, Lancet Infect Dis 2007 7 549 558 10.1016/S1473-3099(07)70187-1 17646028 (Pubitemid 47077715)
20. Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults. Fanello CI, Karema C, van Doren W, Rwagacondo CE, D'Alessandro U, Trop Med Int Health 2006 11 589 596 10.1111/j.1365-3156.2006.01610.x 16640610
21. Effects of amodiaquin and quinidine on cardiac conduction. Kirk BW, Dresel PE, Can J Physiol Pharmacol 1965 43 29 38 10.1139/y65-004 14324229
22. Site of origin of bigeminal rhythms produced by amodiaquin in the dog. Bose D, Dresel PE, Am J Physiol 1971 220 1866 1870 5087836
23. Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia. Brachmann J, Scherlag BJ, Rosenshtraukh LV, Lazzara R, Circulation 1983 68 846 856 10.1161/01.CIR.68.4.846 6616779 (Pubitemid 13019233)
24. Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes. Kurita T, Ohe T, Marui N, Aihara N, Takaki H, Kamakura S, Matsuhisa M, Shimomura K, Am J Cardiol 1992 69 628 633 10.1016/0002-9149(92)90154-Q 1536113
25. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria. Touze JE, Bernard J, Keundjian A, Imbert P, Viguier A, Chaudet H, Doury JC, Am J Trop Med Hyg 1996 54 225 228 8600754 (Pubitemid 26100705)
26. Quinine pharmacokinetics: ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria. Claessen FA, van Boxtel CJ, Perenboom RM, Tange RA, Wetsteijn JC, Kager PA, Trop Med Int Health 1998 3 482 489 10.1046/j.1365-3156.1998.00252.x 9657511 (Pubitemid 28283574)
27. The effects of antimalarial drugs on ventricular repolarization. Touze JE, Heno P, Fourcade L, Deharo JC, Thomas G, Bohan S, Paule P, Riviere P, Kouassi E, Buguet A, Am J Trop Med Hyg 2002 67 54 60 12363064 (Pubitemid 35034320)
28. Fatal quinine cardiotoxicity in the treatment of falciparum malaria. Bonington A, Davidson RN, Winstanley PA, Pasvol G, Trans R Soc Trop Med Hyg 1996 90 305 307 10.1016/S0035-9203(96)90264-3 8758086 (Pubitemid 26188883)
29. QTc interval in the assessment of cardiac risk. Elming H, Brendorp B, Køber L, Sahebzadah N, Torp-Petersen C, Card Electrophysiol Rev 2002 6 289 294 10.1023/A:1016345412555 12114854 (Pubitemid 35276940)
30. QT correction methods in children and adolescents. Wernicke JF, Faries D, Breitung R, Girod D, J Cardiovasc Electrophysiol 2005 16 76 81 10.1046/j.1540-8167.2005.03520.x 15673393 (Pubitemid 40165457)